BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sassaki LY, Miszputen SJ, Kaiser Junior RL, Catapani WR, Bafutto M, Scotton AS, Zaltman C, Baima JP, Ramos HS, Faria MAG, Gonçalves CD, Guimaraes IM, Flores C, Amarante HMBS, Nones RB, Parente JML, Lima MM, Chebli JM, Ferrari MLA, Campos JF, Sanna MGP, Ramos O, Parra RS, da Rocha JJR, Feres O, Feitosa MR, Caratin RF, Senra JT, Santana GO. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil. World J Gastroenterol 2021; 27(23): 3396-3412 [PMID: 34163120 DOI: 10.3748/wjg.v27.i23.3396]
URL: https://www.wjgnet.com/1007-9327/full/v27/i23/3396.htm
Number Citing Articles
1
Rogerio Serafim Parra, Sandro da Costa Ferreira, Vanessa Foresto Machado, Cintia Maura Caseiro Nigro, José Joaquim Ribeiro da Rocha, Luiz Ernesto de Almeida Troncon, Omar Feres. Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel DiseasesJournal of Clinical Medicine 2023; 12(7): 2672 doi: 10.3390/jcm12072672
2
Emma Calabrese, Sara Onali, Angela Variola, Davide Giuseppe Ribaldone, Edoardo Vincenzo Savarino, Anna Viola, Simone Saibeni, Francesco Simone Conforti, Anna Testa, Giovanni Latella, Ambrogio Orlando, Mariabeatrice Principi, Antonino Carlo Privitera, Maria Guerra, Linda Ceccarelli, Giammarco Mocci, Davide Boy, Maria Adelaide Piccarozzi, Giuliana Gualberti, Francesca Marando, Lorenzo Gemignani, Ferdinando D'Amico. Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST StudyDigestive and Liver Disease 2024;  doi: 10.1016/j.dld.2024.08.040